Stay updated on Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction
Sign up to get notified when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.

Latest updates to the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 tag and removed the government funding notice about operations status; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide funding notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a 'Show glossary' option on the page. Updated metadata labels to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision to v3.4.0.SummaryDifference0.2%

- Check64 days agoChange DetectedExpanded the study location data with numerous regional and country locations (e.g., California, Florida, Georgia, Kansas, Maryland, New York, North Carolina, Ohio, Texas; New South Wales, Queensland, Victoria, Western Australia; Ontario, Quebec; Chiba, Hokkaido, Ishikawa-ken, Saitama) and removed the HHS Vulnerability Disclosure link. Revision updated to v3.3.3.SummaryDifference2%

- Check85 days agoChange DetectedFooter revision tag updated to Revision: v3.3.2, replacing v3.3.1; no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check92 days agoChange DetectedPublications section wording updated to 'automatically filled from PubMed' and the revision tag changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction
Enter your email address, and we'll notify you when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.